US20100168781A1 - Expandable body cavity liner device - Google Patents
Expandable body cavity liner device Download PDFInfo
- Publication number
- US20100168781A1 US20100168781A1 US12/721,834 US72183410A US2010168781A1 US 20100168781 A1 US20100168781 A1 US 20100168781A1 US 72183410 A US72183410 A US 72183410A US 2010168781 A1 US2010168781 A1 US 2010168781A1
- Authority
- US
- United States
- Prior art keywords
- aneurysm
- expandable liner
- liner
- guidewire
- extender coil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
Definitions
- the present invention deals with a system for treating a vascular cavity. More specifically, the present invention is directed to vascular cavity liners and vascular cavity neck bridges.
- Aneurysm or vascular malformation is a localized stretching or distension of an artery due to a weakening of the vessel wall.
- “berry” aneurysms i.e., small spherical distensions, occur in the vessels of the brain.
- Alternative treatments include endovascular occlusion where the interior of the aneurysm is entered with a guidewire or a microcatheter. An occlusion is formed within the sac with an intention to preserve the parent artery.
- One means for forming a mass is through the introduction of an embolic agent within the sac. Examples of embolic agents include a detachable coil, which is detached from the end of a guidewire, a liquid polymer which polymerizes rapidly on contact with blood to form a firm mass, and embolic particles.
- Endovascular occlusion is not without drawbacks. For example, there is a risk of overfilling the sac and consequent embolic agent migration into the parent vessel. Overfilling of the sac also generates additional pressure in the aneurysm.
- Another means for forming a mass in the aneurysm sac involves the placement of an elastic, expandable balloon or liner in the aneurysm.
- Detachable occlusion balloons have been used for a number of medical procedures. These balloons are carried at the end of a catheter and, once inflated can be detached from the catheter. Such a balloon may be positioned within an aneurysm, filled and then detached from the catheter. Deploying the balloon within the aneurysm can be rather difficult due to the high rates of blood flow through the aneurysm.
- Elastic balloons have exhibited problems with respect to performance and have not been used endovascularly in some time.
- This aneurysm filling technique also has its problems. As the balloon is filled, the operator must be very careful not to overfill the balloon due to possible risk of rupturing the aneurysm. Accordingly, the balloon may be too small, potentially resulting in the release of the balloon from the aneurysm into the blood stream. Furthermore, the balloon often does not mold or shape to the odd-shaped contours of the aneurysm leaving room for blood to continue flowing through the aneurysm, or generating undesired pressure on the aneurysm wall.
- Aneurysm liners are composed of a liner sac which is placed in the aneurysm and filled to occlude the aneurysm.
- a guidewire is inserted in the liner.
- the guidewire carries the liner through the vasculature to deploy the liner in the aneurysm.
- aneurysm liner concept is intuitively attractive, it has posed a number of technical challenges.
- One primary challenge involves the difficulty in producing a material that is robust enough to contain embolic material without inhibiting the ability of the embolics to conform to the aneurysm geometry itself, rather than the geometry of the liner.
- the elastic materials discussed above generally require to much force to deform, and inelastic materials that deform readily do not have adequate memory to conform to the aneurysmal wall.
- aneurysms which have a particularly wide opening between the aneurysm sac and the parent vessel (“wide neck aneurysms”) present difficulties concerning the retention of embolic materials. Specifically, wide neck aneurysms make if very difficult to maintain the embolics, or occlusive materials, within the aneurysmal sac. This is especially true of liquid embolic materials. Of course, should the embolic material enter the parent vessel, it poses an undesirable risk of occlusion in the parent vessel.
- some liner concepts involve forming the aneurysm liner of a woven or braided polymeric material such as polypropylene, polyester, nylon, urethane, teflon, etc.
- these mesh materials are difficult to use in treating aneurysms larger than, for example, twelve millimeters in diameter. Such mesh materials result in an assembly which is too bulky when collapsed down onto the catheter for delivery. In other words, the amount of materials required to fill a relatively large aneurysm is very difficult to collapse down into a constrained, low profile, delivery configuration small enough to be delivered and deployed without excess friction on the walls of the delivery catheter or other delivery lumen.
- the present invention is a vascular cavity treatment device for treating vascular cavities of various shapes and sizes and will be discussed by way of example as an aneurysm treatment device.
- the aneurysm treatment device includes an aneurysm liner formed of material having very low yield strength and very low elasticity so that, with a relatively low amount of internal pressure exerted by, for example, embolic material, the aneurysm liner readily plastically deforms to the internal geometry of the aneurysm sac.
- a second, reinforcing layer is deployed on the first material.
- the reinforcing layer is more elastic than the first material and has a much higher yield strength.
- the reinforcing layer is illustratively disposed at the neck of the aneurysm liner device.
- FIGS. 1A-1C illustrate the deployment of an aneurysm liner in an aneurysm.
- FIGS. 2A-2C illustrate an embodiment of an aneurysm liner being formed of materials with two different characteristics, one of them having a very low yield strength and the other having a high yield strength and a greater elasticity.
- FIG. 2D illustrates the embodiment shown in FIGS. 2A-2C , with perforations therein.
- FIGS. 3A-3C illustrate an embodiment of an aneurysm liner being formed of a balloon material having two different characteristics, portions thereof being weaker than other portions thereof.
- FIG. 3D illustrates the embodiment shown in FIGS. 3A-3C with perforations therein.
- FIGS. 1A-1C illustrate a portion of an aneurysm treatment device 10 in a vessel 12 which has an aneurysm 14 therein, and thus illustrate the general context of the present invention.
- Aneurysm 14 is defined by aneurysmal sac 16 and neck 18 .
- Device 10 includes, in the embodiment illustrated, delivery catheter 18 , a pair of extender coils 21 and 22 and an expandable liner 24 (aneurysm liner sac).
- Delivery catheter 20 has a proximal end that extends proximally to a position where it is manipulable by an operator.
- Coils 21 and 22 can either be attached to the liner or catheter, or unattached. In addition, there can also be one or more coils disposed between coils 21 and 22 and axially aligned therewith.
- coils 21 and 22 When in the insertion position shown in FIG. 1A , coils 21 and 22 (and other optional coils therebetween) are axially aligned with one another, their length is sufficient to substantially hold liner 24 in a low profile position for insertion and manipulation within the vasculature.
- coils 21 and 22 are axially aligned with one another and with catheter 20 through the use of a guidewire 26 which is disposed within the lumen of catheter 20 , through coils 21 and 22 and liner 24 , and out the distal end of catheter 22 and liner 24 .
- Coils 21 and 22 are held in an axially aligned conformation by guidewire 26 such that coils 21 and 22 substantially conform to the curvature of guidewire 26 .
- Coils 21 and 22 rather than guidewire 26 , can act to extend and even tension liner 24 .
- FIG. 1B shows that treatment device 10 has been positioned through vessel 12 and neck 18 into the sac 16 of aneurysm 14 . Similar items are similarly numbered to those shown in FIG. 1A .
- aneurysm treatment device 10 can be preloaded or back loaded onto guidewire 26 .
- Guidewire 26 is manipulated through the vasculature from the entry site (such as the femoral artery) to the region of vessel 12 containing the aneurysm.
- the distal tip of guidewire 26 is advanced across the neck 18 of aneurysm 14 and into the aneurysm sac 16 . This can be done using any desirable visualization technique.
- catheter 20 is placed over guidewire 26 prior to positioning guidewire 26 in the vasculature, with several centimeters of guidewire 26 extending distal of the distal tip of catheter 20 . Therefore, when the distal end of guidewire 26 has passed the aneurysm neck 18 , catheter 20 is positioned just proximal of neck 18 . Treatment device 10 is then advanced into the aneurysm sac 16 .
- guidewire 26 is placed in the vasculature first. Once the distal end of guidewire 26 is moved past the aneurysm neck 18 , into the aneurysm sac 16 , catheter 20 is advanced over guidewire 26 such that the extender coils 21 and 22 are pushed distally along the guidewire by the catheter 20 until the aneurysm treatment device 10 is in place in the aneurysm sac 16 .
- FIG. 1C illustrates treatment device 10 deployed in aneurysm sac 16 in accordance with one embodiment. Similar items are similarly numbered to those shown in FIGS. 1A and 1B .
- guidewire 26 is retracted proximally, but liner 24 remains connected to delivery catheter 20 .
- the distal end of delivery catheter 20 holds expandable liner 24 in position within the aneurysm sac 16 while expandable liner 24 is filled with embolics. Expansion of liner 24 occurs after the distal end of guidewire 26 is retracted from the coils 21 and 22 .
- coils 21 and 22 recoil away from axial alignment with one another toward the periphery of liner 24 .
- coils 21 and 22 are biased to extend in opposite directions to enhance deployment of, and expansion of, liner 24 within aneurysm sac 16 . If any coils are disposed between coils 21 and 22 on guidewire 26 , they simply fall away and float within liner 24 . Embolic material can now be introduced into liner 24 through catheter 20 using substantially any desired method.
- Such methods include, for example, advancing coils or particles into liner 24 , pushing the embolic material into catheter 20 with guidewire 26 completely removed, or infusing or injecting embolic material through catheter 20 into liner 24 .
- Liner 24 is thus filled with a common embolic agent, such as detachable coils, particles, acrylics, hydrogel, etc.
- liner 24 Once liner 24 is filled, it is unable to be removed through aneurysm neck 18 . Therefore, it is released from delivery catheter 20 and delivery catheter 20 is removed from the treatment site. Detachment of liner 24 from catheter 20 can be accomplished using any desired method, such as using electrolytic detachment, traction-based detachment, or other mechanical, electrical, heat-based, magnetic, chemical or other detachment.
- FIGS. 1A-1C illustrate that device 10 is configured for convenient treatment of aneurysm 14 , and in particular, a generally symmetrically shaped aneurysm.
- asymmetrically shaped aneurysm sacs or those having an otherwise irregular geometrical shape present other problems.
- aneurysm sac 16 had a cavity extending out one side thereof, it may be difficult for liner 24 to fill that portion of the aneurysm sac.
- FIGS. 2A and 2B illustrate yet another embodiment of an aneurysm treatment device 40 in accordance with another embodiment of the present invention.
- Aneurysm treatment device 40 is similar, in many ways, to the previous embodiments, in that it can illustratively include interior extender coils 21 and 22 (and optional coils therebetween) and can be positioned over a guidewire 26 using a detachable delivery catheter 20 .
- Treatment device 40 also illustratively includes a liner 24 .
- treatment device 40 also includes other or different features.
- FIG. 2A shows treatment device 40 having already been positioned within an asymmetrical aneurysm sac 16 , which has a highly irregular geometry.
- FIG. 2A shows that treatment device 40 not only includes liner (first portion) 24 , but also illustratively includes a reinforcing layer (or second portion) 42 . Liner 24 and layer 42 are described in greater detail below.
- FIG. 2B shows partial deployment of aneurysm liner 24 after guidewire 26 has been removed and extender coils 21 and 22 fall away from axial alignment with one another.
- Liner 24 is also at least partially expanded to the position shown in FIG. 2B through the introduction of embolic material therein to slightly elevate the internal pressure in liner 24 above ambient (e.g., 0-1 ATM), using catheter 20 .
- liner 24 is illustratively formed of a polymer that has a very low yield strength and a low elasticity so that, with a minimal amount of additional force exerted by the embolic material (e.g., 0-5 ATM and illustratively 0-2 ATM or 1-2 ATM), the polymer material forming liner 24 readily plastically expands to conform to the interior perimeter of aneurysmal sac 16 . This is illustrated in FIG. 2C .
- liner 24 is formed of a polymer having characteristics such that by the continued introduction of embolic material into liner 24 , liner 24 simply permanently deforms to assume the shape of the aneurysm sac 16 .
- the material which forms liner 24 also has sufficient ultimate failure strength so as not to tear during delivery or expansion thereof
- reinforcement layer 42 is more elastic and of a much higher yield strength.
- Reinforcement layer 42 is illustratively located in the region of aneurysm liner 24 close to its attachment point to catheter 20 (neck portion). This ensures that it will be located preferentially near aneurysm neck 18 in order to prevent aneurysm liner 24 from expanding through neck 18 , and into parent vessel 12 .
- the distal end of treatment device 40 can easily expand into the irregular geometrical portions of the aneurysmal sac, while the proximal portion thereof does not deform as easily and thus prevents deformation into parent vessel 12 .
- Reinforcement layer 42 can also be discontinuous or formed of a braid or mesh or polymer material or other reinforcing material and can be radiopaque as well.
- FIG. 2D shows another embodiment of treatment device 40 with perforations formed therein. These perforations allow blood to escape from the aneurysmal sac, through liner 24 , and reinforcing layer 42 , into the parent vessel 12 , as liner 24 is expanded. However, as with the previous embodiments, the perforations are not necessary and the blood can simply escape around the outside of device 40 and through neck 18 . Also, the perforations are shown as being larger distally, to allow distal permeation of embolics, although this is optional as well.
- spherical PVA embolics may traditionally be 500 microns in size and may be used to fill a conventional aneurysm liner.
- the distal portion of device 40 can thus be perforated with 750 micron holes whereas the proximal portion near the neck 18 of aneurysm sac 16 can illustratively be perforated with 350 micron sized, irregularly distributed, holes. Therefore, as the embolics are introduced into liner portion 24 , they are sized to be able to escape the distal end thereof and or occupy the irregular spaces in the aneurysm sac 16 , without escaping back into the parent vessel 12 .
- FIGS. 3A-3C illustrate another embodiment of an aneurysm treatment device 50 in accordance with one aspect of the present invention. Similar items are similarly numbered to those shown in previous Figures.
- Treatment device 50 is similar, in many ways, to the previous embodiments in that it can illustratively include interior extender coils 21 and 22 (and optional coils therebetween) and can be positioned over a guidewire 26 using a detachable delivery catheter 20 .
- Treatment device 50 also illustratively includes a liner 51 .
- treatment device 50 also illustratively includes other or different features.
- FIG. 3A shows treatment device 50 having already been positioned within an asymmetrical aneurysm sac 52 , which has a highly irregular geometry.
- liner 51 is illustratively formed as a detachable balloon.
- the balloon material illustratively has a plurality of areas 54 disposed on its surface which are weaker (or more elastic) than the remainder of the surface of liner 51 .
- areas 54 are simply formed of thinner balloon material than the remainder of liner 51 .
- they could be formed of different, more elastic (or weaker) material, or the remainder of liner 51 (other than areas 54 ) can be enclosed in a braid, a mesh, a polymer material or otherwise coated with a material which precludes that portion of liner 51 from expanding beyond a predetermined geometry and may be radiopaque as well.
- FIG. 3B illustrates aneurysm treatment device 50 expanded under a first predetermined pressure.
- liner 51 is inflated with a contrast medium, or saline solution, or another fluid introduced through catheter 20 . As the pressure in liner 51 increases, liner 51 inflates to a first predetermined dimension in which areas 54 are not expanded beyond the remainder of liner 51 .
- FIG. 3C illustrates liner 51 , after it has been subjected to additional internal pressure. It can be seen that liner 51 has now assumed an irregular shape because the weaker regions 54 have expanded to fill void spaces of aneurysm sac 52 . This allows liner 51 to substantially fill even irregularly shaped aneurysm sac 52 .
- FIG. 3C also illustrates that, in a region of liner 51 proximate neck 18 of the aneurysm there are no weak zones 54 . This helps to preclude any portion of the aneurysm liner 51 from expanding into parent vessel 12 , and thereby fully or partially occluding the vessel.
- liner 51 need not even substantially fill the entire aneurysm sac 52 .
- liner 51 can simply be inflated to a geometry in which enough of the weaker regions 54 have been expanded into void spaces or lobes of aneurysm sac 52 to securely anchor liner 51 within aneurysm sac 52 and to block the inflow zone through neck 18 .
- the neck 18 is blocked and device 50 is anchored in place to inhibit further growth of the aneurysm.
- aneurysm liner 51 can be filled with embolics or other polymeric materials, or coils. This may enhance the long term stability of liner 51 within aneurysm sac 52 .
- FIG. 3D is another illustrative embodiment of the present invention.
- FIG. 3D is similar to the embodiment illustrated in FIGS. 3A-3C , except that it has perforations therein.
- Weak regions 54 are illustrated by dashed lines while the perforations are illustrated by either points or circular or oval shaped regions.
- the perforations allow introduced embolic material to seek out the void spaces, or irregular lobes, of aneurysm sac 52 .
- the perforations also allow blood that is being displaced in aneurysm sac 52 to re-enter parent vessel 12 through aneurysm liner 51 .
- the embodiment in FIG. 3D shows that the perforations can be formed to preferentially permeate embolics distally.
- the distal perforations are larger than the proximal perforations such that embolics can permeate the distal perforations but not the proximal perforations.
- the presence of the perforations are optional, as is the sizing of any perforations which may be used.
- weak regions can be other shapes as well, such as annular rings around liner 51 , axial stripes or substantially any geometric shape.
- biodegradable, cell growth enhancing material such as polyglycolic acid (PGA) or polylactic acid (PLA) disposed thereon in a region that will illustratively be deployed in a neck region of the aneurysm.
- PGA polyglycolic acid
- PLA polylactic acid
- the devices described herein can be releasably attached to guidewire 26 instead of the catheter.
- the present invention provides a number of different embodiments for treating aneurysms. These embodiments address many of the various deficiencies and disadvantages associated with prior aneurysm treatment devices.
Abstract
Description
- This application is a continuation of co-pending U.S. patent application Ser. No. 10/107,689, filed Mar. 27, 2002, the priority of which is claimed under 35 U.S.C. §120, and the contents of which is incorporated herein by reference in its entirety, as though set forth in full.
- The present invention deals with a system for treating a vascular cavity. More specifically, the present invention is directed to vascular cavity liners and vascular cavity neck bridges.
- While the present discussion proceeds with respect to aneurysms, it will be appreciated that it can be applied to other vascular cavities (such as vessels, lumens, etc.) as well. An aneurysm or vascular malformation is a localized stretching or distension of an artery due to a weakening of the vessel wall. For example, “berry” aneurysms, i.e., small spherical distensions, occur in the vessels of the brain. The distension—often referred to as the aneurysm sac—is related to defects in the muscular coating of the artery and is probably degenerative in origin. Rupture of aneurysms account for the majority of spontaneous hemorrhages. Approximately 25,000 intracranial aneurysms rupture every year in North America.
- Several methods of treating aneurysms have been attempted, with varying degrees of success. At present, the treatment of aneurysms with drugs is substantially ineffective. Also, extra-vascular surgery, referred to as open craniotomy, for the purpose of preserving the parent artery is replete with disadvantages. A patient subject to open craniotomy for intercranial aneurysms typically must undergo general anesthesia, surgical removal of part of the skull, brain retraction, dissection around the neck of the sac, and placement of a clip on the parent artery to prevent bleeding or rebleeding.
- Alternative treatments include endovascular occlusion where the interior of the aneurysm is entered with a guidewire or a microcatheter. An occlusion is formed within the sac with an intention to preserve the parent artery. One means for forming a mass is through the introduction of an embolic agent within the sac. Examples of embolic agents include a detachable coil, which is detached from the end of a guidewire, a liquid polymer which polymerizes rapidly on contact with blood to form a firm mass, and embolic particles.
- Endovascular occlusion is not without drawbacks. For example, there is a risk of overfilling the sac and consequent embolic agent migration into the parent vessel. Overfilling of the sac also generates additional pressure in the aneurysm.
- Another means for forming a mass in the aneurysm sac involves the placement of an elastic, expandable balloon or liner in the aneurysm. Detachable occlusion balloons have been used for a number of medical procedures. These balloons are carried at the end of a catheter and, once inflated can be detached from the catheter. Such a balloon may be positioned within an aneurysm, filled and then detached from the catheter. Deploying the balloon within the aneurysm can be rather difficult due to the high rates of blood flow through the aneurysm. Elastic balloons have exhibited problems with respect to performance and have not been used endovascularly in some time.
- This aneurysm filling technique also has its problems. As the balloon is filled, the operator must be very careful not to overfill the balloon due to possible risk of rupturing the aneurysm. Accordingly, the balloon may be too small, potentially resulting in the release of the balloon from the aneurysm into the blood stream. Furthermore, the balloon often does not mold or shape to the odd-shaped contours of the aneurysm leaving room for blood to continue flowing through the aneurysm, or generating undesired pressure on the aneurysm wall.
- Aneurysm liners are composed of a liner sac which is placed in the aneurysm and filled to occlude the aneurysm. A guidewire is inserted in the liner. The guidewire carries the liner through the vasculature to deploy the liner in the aneurysm.
- All of the present systems for treating aneurysms have disadvantages as well. For example, while the aneurysm liner concept is intuitively attractive, it has posed a number of technical challenges. One primary challenge involves the difficulty in producing a material that is robust enough to contain embolic material without inhibiting the ability of the embolics to conform to the aneurysm geometry itself, rather than the geometry of the liner. For example, the elastic materials discussed above generally require to much force to deform, and inelastic materials that deform readily do not have adequate memory to conform to the aneurysmal wall.
- Different types of aneurysms also present different challenges. For example, aneurysms which have a particularly wide opening between the aneurysm sac and the parent vessel (“wide neck aneurysms”) present difficulties concerning the retention of embolic materials. Specifically, wide neck aneurysms make if very difficult to maintain the embolics, or occlusive materials, within the aneurysmal sac. This is especially true of liquid embolic materials. Of course, should the embolic material enter the parent vessel, it poses an undesirable risk of occlusion in the parent vessel.
- Some current aneurysm liner concepts are inadequate in treating larger aneurysms.
- For example, some liner concepts involve forming the aneurysm liner of a woven or braided polymeric material such as polypropylene, polyester, nylon, urethane, teflon, etc. However, these mesh materials are difficult to use in treating aneurysms larger than, for example, twelve millimeters in diameter. Such mesh materials result in an assembly which is too bulky when collapsed down onto the catheter for delivery. In other words, the amount of materials required to fill a relatively large aneurysm is very difficult to collapse down into a constrained, low profile, delivery configuration small enough to be delivered and deployed without excess friction on the walls of the delivery catheter or other delivery lumen.
- The present invention is a vascular cavity treatment device for treating vascular cavities of various shapes and sizes and will be discussed by way of example as an aneurysm treatment device.
- In one embodiment, the aneurysm treatment device includes an aneurysm liner formed of material having very low yield strength and very low elasticity so that, with a relatively low amount of internal pressure exerted by, for example, embolic material, the aneurysm liner readily plastically deforms to the internal geometry of the aneurysm sac. A second, reinforcing layer is deployed on the first material. The reinforcing layer is more elastic than the first material and has a much higher yield strength. The reinforcing layer is illustratively disposed at the neck of the aneurysm liner device.
-
FIGS. 1A-1C illustrate the deployment of an aneurysm liner in an aneurysm. -
FIGS. 2A-2C illustrate an embodiment of an aneurysm liner being formed of materials with two different characteristics, one of them having a very low yield strength and the other having a high yield strength and a greater elasticity. -
FIG. 2D illustrates the embodiment shown inFIGS. 2A-2C , with perforations therein. -
FIGS. 3A-3C illustrate an embodiment of an aneurysm liner being formed of a balloon material having two different characteristics, portions thereof being weaker than other portions thereof. -
FIG. 3D illustrates the embodiment shown inFIGS. 3A-3C with perforations therein. -
FIGS. 1A-1C illustrate a portion of ananeurysm treatment device 10 in avessel 12 which has ananeurysm 14 therein, and thus illustrate the general context of the present invention. Though the embodiments discussed herein are discussed in conjunction with an aneurysm, it will be appreciated that they can be used in substantially any vascular cavity or other bodily cavities.Aneurysm 14 is defined byaneurysmal sac 16 andneck 18.Device 10 includes, in the embodiment illustrated,delivery catheter 18, a pair of extender coils 21 and 22 and an expandable liner 24 (aneurysm liner sac).Delivery catheter 20 has a proximal end that extends proximally to a position where it is manipulable by an operator. The distal end ofcatheter 20 is releaseably connected to theliner 24 andcoil 21.Coils coils - When in the insertion position shown in
FIG. 1A , coils 21 and 22 (and other optional coils therebetween) are axially aligned with one another, their length is sufficient to substantially holdliner 24 in a low profile position for insertion and manipulation within the vasculature. In one embodiment, coils 21 and 22 are axially aligned with one another and withcatheter 20 through the use of aguidewire 26 which is disposed within the lumen ofcatheter 20, throughcoils liner 24, and out the distal end ofcatheter 22 andliner 24.Coils guidewire 26 such that coils 21 and 22 substantially conform to the curvature ofguidewire 26.Coils tension liner 24. -
FIG. 1B shows thattreatment device 10 has been positioned throughvessel 12 andneck 18 into thesac 16 ofaneurysm 14. Similar items are similarly numbered to those shown inFIG. 1A . In use,aneurysm treatment device 10 can be preloaded or back loaded ontoguidewire 26.Guidewire 26 is manipulated through the vasculature from the entry site (such as the femoral artery) to the region ofvessel 12 containing the aneurysm. The distal tip ofguidewire 26 is advanced across theneck 18 ofaneurysm 14 and into theaneurysm sac 16. This can be done using any desirable visualization technique. In one embodiment,catheter 20 is placed overguidewire 26 prior topositioning guidewire 26 in the vasculature, with several centimeters ofguidewire 26 extending distal of the distal tip ofcatheter 20. Therefore, when the distal end ofguidewire 26 has passed theaneurysm neck 18,catheter 20 is positioned just proximal ofneck 18.Treatment device 10 is then advanced into theaneurysm sac 16. - In another embodiment, guidewire 26 is placed in the vasculature first. Once the distal end of
guidewire 26 is moved past theaneurysm neck 18, into theaneurysm sac 16,catheter 20 is advanced overguidewire 26 such that the extender coils 21 and 22 are pushed distally along the guidewire by thecatheter 20 until theaneurysm treatment device 10 is in place in theaneurysm sac 16. -
FIG. 1C illustratestreatment device 10 deployed inaneurysm sac 16 in accordance with one embodiment. Similar items are similarly numbered to those shown inFIGS. 1A and 1B . Oncedevice 10 is substantially fully withinaneurysm sac 16, guidewire 26 is retracted proximally, butliner 24 remains connected todelivery catheter 20. The distal end ofdelivery catheter 20 holdsexpandable liner 24 in position within theaneurysm sac 16 whileexpandable liner 24 is filled with embolics. Expansion ofliner 24 occurs after the distal end ofguidewire 26 is retracted from thecoils - As shown in
FIG. 1C , once guidewire 26 has been retracted, coils 21 and 22 recoil away from axial alignment with one another toward the periphery ofliner 24. In one illustrative embodiment, coils 21 and 22 are biased to extend in opposite directions to enhance deployment of, and expansion of,liner 24 withinaneurysm sac 16. If any coils are disposed betweencoils guidewire 26, they simply fall away and float withinliner 24. Embolic material can now be introduced intoliner 24 throughcatheter 20 using substantially any desired method. Such methods include, for example, advancing coils or particles intoliner 24, pushing the embolic material intocatheter 20 withguidewire 26 completely removed, or infusing or injecting embolic material throughcatheter 20 intoliner 24.Liner 24 is thus filled with a common embolic agent, such as detachable coils, particles, acrylics, hydrogel, etc. - Once
liner 24 is filled, it is unable to be removed throughaneurysm neck 18. Therefore, it is released fromdelivery catheter 20 anddelivery catheter 20 is removed from the treatment site. Detachment ofliner 24 fromcatheter 20 can be accomplished using any desired method, such as using electrolytic detachment, traction-based detachment, or other mechanical, electrical, heat-based, magnetic, chemical or other detachment. -
FIGS. 1A-1C illustrate thatdevice 10 is configured for convenient treatment ofaneurysm 14, and in particular, a generally symmetrically shaped aneurysm. However, asymmetrically shaped aneurysm sacs, or those having an otherwise irregular geometrical shape present other problems. For example, ifaneurysm sac 16 had a cavity extending out one side thereof, it may be difficult forliner 24 to fill that portion of the aneurysm sac. -
FIGS. 2A and 2B illustrate yet another embodiment of ananeurysm treatment device 40 in accordance with another embodiment of the present invention.Aneurysm treatment device 40 is similar, in many ways, to the previous embodiments, in that it can illustratively include interior extender coils 21 and 22 (and optional coils therebetween) and can be positioned over aguidewire 26 using adetachable delivery catheter 20.Treatment device 40 also illustratively includes aliner 24. - However,
treatment device 40 also includes other or different features.FIG. 2A showstreatment device 40 having already been positioned within anasymmetrical aneurysm sac 16, which has a highly irregular geometry.FIG. 2A shows thattreatment device 40 not only includes liner (first portion) 24, but also illustratively includes a reinforcing layer (or second portion) 42.Liner 24 andlayer 42 are described in greater detail below. -
FIG. 2B shows partial deployment ofaneurysm liner 24 afterguidewire 26 has been removed and extender coils 21 and 22 fall away from axial alignment with one another.Liner 24 is also at least partially expanded to the position shown inFIG. 2B through the introduction of embolic material therein to slightly elevate the internal pressure inliner 24 above ambient (e.g., 0-1 ATM), usingcatheter 20. - In accordance with one embodiment of the present invention,
liner 24 is illustratively formed of a polymer that has a very low yield strength and a low elasticity so that, with a minimal amount of additional force exerted by the embolic material (e.g., 0-5 ATM and illustratively 0-2 ATM or 1-2 ATM), the polymermaterial forming liner 24 readily plastically expands to conform to the interior perimeter ofaneurysmal sac 16. This is illustrated inFIG. 2C . In other words,liner 24 is formed of a polymer having characteristics such that by the continued introduction of embolic material intoliner 24,liner 24 simply permanently deforms to assume the shape of theaneurysm sac 16. The material which formsliner 24 also has sufficient ultimate failure strength so as not to tear during delivery or expansion thereof - In addition,
reinforcement layer 42 is more elastic and of a much higher yield strength.Reinforcement layer 42 is illustratively located in the region ofaneurysm liner 24 close to its attachment point to catheter 20 (neck portion). This ensures that it will be located preferentially nearaneurysm neck 18 in order to preventaneurysm liner 24 from expanding throughneck 18, and intoparent vessel 12. Thus, the distal end oftreatment device 40 can easily expand into the irregular geometrical portions of the aneurysmal sac, while the proximal portion thereof does not deform as easily and thus prevents deformation intoparent vessel 12.Reinforcement layer 42 can also be discontinuous or formed of a braid or mesh or polymer material or other reinforcing material and can be radiopaque as well. -
FIG. 2D shows another embodiment oftreatment device 40 with perforations formed therein. These perforations allow blood to escape from the aneurysmal sac, throughliner 24, and reinforcinglayer 42, into theparent vessel 12, asliner 24 is expanded. However, as with the previous embodiments, the perforations are not necessary and the blood can simply escape around the outside ofdevice 40 and throughneck 18. Also, the perforations are shown as being larger distally, to allow distal permeation of embolics, although this is optional as well. - For example, spherical PVA embolics may traditionally be 500 microns in size and may be used to fill a conventional aneurysm liner. The distal portion of
device 40 can thus be perforated with 750 micron holes whereas the proximal portion near theneck 18 ofaneurysm sac 16 can illustratively be perforated with 350 micron sized, irregularly distributed, holes. Therefore, as the embolics are introduced intoliner portion 24, they are sized to be able to escape the distal end thereof and or occupy the irregular spaces in theaneurysm sac 16, without escaping back into theparent vessel 12. -
FIGS. 3A-3C illustrate another embodiment of ananeurysm treatment device 50 in accordance with one aspect of the present invention. Similar items are similarly numbered to those shown in previous Figures.Treatment device 50 is similar, in many ways, to the previous embodiments in that it can illustratively include interior extender coils 21 and 22 (and optional coils therebetween) and can be positioned over aguidewire 26 using adetachable delivery catheter 20.Treatment device 50 also illustratively includes aliner 51. - However,
treatment device 50 also illustratively includes other or different features.FIG. 3A showstreatment device 50 having already been positioned within anasymmetrical aneurysm sac 52, which has a highly irregular geometry. - In the embodiment shown in
FIG. 3A ,liner 51 is illustratively formed as a detachable balloon. The balloon material illustratively has a plurality ofareas 54 disposed on its surface which are weaker (or more elastic) than the remainder of the surface ofliner 51. In one illustrative embodiment,areas 54 are simply formed of thinner balloon material than the remainder ofliner 51. Of course, they could be formed of different, more elastic (or weaker) material, or the remainder of liner 51 (other than areas 54) can be enclosed in a braid, a mesh, a polymer material or otherwise coated with a material which precludes that portion ofliner 51 from expanding beyond a predetermined geometry and may be radiopaque as well. -
FIG. 3B illustratesaneurysm treatment device 50 expanded under a first predetermined pressure. In one illustrative embodiment,liner 51 is inflated with a contrast medium, or saline solution, or another fluid introduced throughcatheter 20. As the pressure inliner 51 increases,liner 51 inflates to a first predetermined dimension in whichareas 54 are not expanded beyond the remainder ofliner 51. -
FIG. 3C illustratesliner 51, after it has been subjected to additional internal pressure. It can be seen thatliner 51 has now assumed an irregular shape because theweaker regions 54 have expanded to fill void spaces ofaneurysm sac 52. This allowsliner 51 to substantially fill even irregularly shapedaneurysm sac 52.FIG. 3C also illustrates that, in a region ofliner 51proximate neck 18 of the aneurysm there are noweak zones 54. This helps to preclude any portion of theaneurysm liner 51 from expanding intoparent vessel 12, and thereby fully or partially occluding the vessel. - It should also be noted that, in one illustrative embodiment,
liner 51 need not even substantially fill theentire aneurysm sac 52. Instead,liner 51 can simply be inflated to a geometry in which enough of theweaker regions 54 have been expanded into void spaces or lobes ofaneurysm sac 52 to securely anchorliner 51 withinaneurysm sac 52 and to block the inflow zone throughneck 18. In that embodiment, even if theentire aneurysm sac 52 is not filled, theneck 18 is blocked anddevice 50 is anchored in place to inhibit further growth of the aneurysm. - In another illustrative embodiment,
aneurysm liner 51 can be filled with embolics or other polymeric materials, or coils. This may enhance the long term stability ofliner 51 withinaneurysm sac 52. -
FIG. 3D is another illustrative embodiment of the present invention.FIG. 3D is similar to the embodiment illustrated inFIGS. 3A-3C , except that it has perforations therein.Weak regions 54 are illustrated by dashed lines while the perforations are illustrated by either points or circular or oval shaped regions. The perforations allow introduced embolic material to seek out the void spaces, or irregular lobes, ofaneurysm sac 52. The perforations also allow blood that is being displaced inaneurysm sac 52 to re-enterparent vessel 12 throughaneurysm liner 51. Further, the embodiment inFIG. 3D shows that the perforations can be formed to preferentially permeate embolics distally. In other words, the distal perforations are larger than the proximal perforations such that embolics can permeate the distal perforations but not the proximal perforations. However, the presence of the perforations are optional, as is the sizing of any perforations which may be used. - Further, weak regions can be other shapes as well, such as annular rings around
liner 51, axial stripes or substantially any geometric shape. - It should further be noted that all of the embodiments discussed herein can optionally have biodegradable, cell growth enhancing material such as polyglycolic acid (PGA) or polylactic acid (PLA) disposed thereon in a region that will illustratively be deployed in a neck region of the aneurysm. Of course, other material or combinations of these materials may be used as well.
- Also, the devices described herein can be releasably attached to guidewire 26 instead of the catheter.
- It can thus be seen that the present invention provides a number of different embodiments for treating aneurysms. These embodiments address many of the various deficiencies and disadvantages associated with prior aneurysm treatment devices.
- Although the present invention has been described with reference to illustrative embodiments, workers skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/721,834 US20100168781A1 (en) | 2002-03-27 | 2010-03-11 | Expandable body cavity liner device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/107,689 US7695488B2 (en) | 2002-03-27 | 2002-03-27 | Expandable body cavity liner device |
US12/721,834 US20100168781A1 (en) | 2002-03-27 | 2010-03-11 | Expandable body cavity liner device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/107,689 Continuation US7695488B2 (en) | 2002-03-27 | 2002-03-27 | Expandable body cavity liner device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100168781A1 true US20100168781A1 (en) | 2010-07-01 |
Family
ID=28452693
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/107,689 Expired - Fee Related US7695488B2 (en) | 2002-03-27 | 2002-03-27 | Expandable body cavity liner device |
US12/721,834 Abandoned US20100168781A1 (en) | 2002-03-27 | 2010-03-11 | Expandable body cavity liner device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/107,689 Expired - Fee Related US7695488B2 (en) | 2002-03-27 | 2002-03-27 | Expandable body cavity liner device |
Country Status (6)
Country | Link |
---|---|
US (2) | US7695488B2 (en) |
EP (1) | EP1487354A1 (en) |
JP (2) | JP2005527271A (en) |
AU (1) | AU2003218420A1 (en) |
CA (1) | CA2477380A1 (en) |
WO (1) | WO2003082128A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014117127A1 (en) * | 2013-01-28 | 2014-07-31 | Neurodynamics, LLC | Embolic coil delivery system and method of using same |
US9277923B2 (en) | 2009-03-31 | 2016-03-08 | Barking Havering & Redbridge Hospitals Nhs Trust | Balloon assisted occlusion of aneurysms |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11058430B2 (en) | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11272939B2 (en) | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US11583282B2 (en) | 2019-05-21 | 2023-02-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11583288B2 (en) | 2018-08-08 | 2023-02-21 | DePuy Synthes Products, Inc. | Delivery of embolic braid |
US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
US11672543B2 (en) | 2017-02-23 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm method and system |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7662161B2 (en) | 1999-09-13 | 2010-02-16 | Rex Medical, L.P | Vascular hole closure device |
US8083766B2 (en) * | 1999-09-13 | 2011-12-27 | Rex Medical, Lp | Septal defect closure device |
US7267679B2 (en) | 1999-09-13 | 2007-09-11 | Rex Medical, L.P | Vascular hole closure device |
US7942888B2 (en) | 1999-09-13 | 2011-05-17 | Rex Medical, L.P. | Vascular hole closure device |
US6802851B2 (en) * | 2001-09-20 | 2004-10-12 | Gordia Neurovascular, Inc. | Stent aneurysm embolization method using collapsible member and embolic coils |
US6811560B2 (en) * | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
US20080208160A9 (en) * | 2003-01-10 | 2008-08-28 | Mawad Michel E | Microcatheter including swellable tip |
US7632291B2 (en) | 2003-06-13 | 2009-12-15 | Trivascular2, Inc. | Inflatable implant |
US20050149109A1 (en) * | 2003-12-23 | 2005-07-07 | Wallace Michael P. | Expanding filler coil |
US7842069B2 (en) * | 2004-05-07 | 2010-11-30 | Nmt Medical, Inc. | Inflatable occluder |
EP1793744B1 (en) | 2004-09-22 | 2008-12-17 | Dendron GmbH | Medical implant |
ATE448737T1 (en) | 2004-09-22 | 2009-12-15 | Dendron Gmbh | DEVICE FOR IMPLANTING MICROWL COILS |
WO2007006139A1 (en) * | 2005-07-12 | 2007-01-18 | Smart Biotech Inc. | Aneurysm occlusion device |
JP5171804B2 (en) * | 2006-03-14 | 2013-03-27 | サーモピューティックス インコーポレイテッド | Aneurysm coil delivery system |
CN101448464B (en) | 2006-04-17 | 2011-05-04 | 微治疗公司 | System and method for mechanically positioning intravascular implants |
US20070288083A1 (en) * | 2006-05-12 | 2007-12-13 | Hines Richard A | Exclusion Device and System For Delivery |
US8372114B2 (en) * | 2006-11-13 | 2013-02-12 | Electroformed Stents, Inc. | Over-the-wire exclusion device and system for delivery |
ES2437619T3 (en) | 2007-03-13 | 2014-01-13 | Covidien Lp | An implant that includes a helical winding and a stretch resistant element |
EP2157937B1 (en) | 2007-06-04 | 2017-03-22 | Sequent Medical, Inc. | Devices for treatment of vascular defects |
AU2008276658B2 (en) | 2007-07-13 | 2013-10-03 | Rex Medical, Lp | Vascular hole closure device |
EP2214580B1 (en) | 2007-11-16 | 2013-05-22 | Synthes GmbH | Porous containment device for stabilization of vertebral compression fractures |
US8920463B2 (en) | 2008-02-15 | 2014-12-30 | Rex Medical, L.P. | Vascular hole closure device |
US8070772B2 (en) | 2008-02-15 | 2011-12-06 | Rex Medical, L.P. | Vascular hole closure device |
US9226738B2 (en) | 2008-02-15 | 2016-01-05 | Rex Medical, L.P. | Vascular hole closure delivery device |
US8920462B2 (en) | 2008-02-15 | 2014-12-30 | Rex Medical, L.P. | Vascular hole closure device |
US8491629B2 (en) | 2008-02-15 | 2013-07-23 | Rex Medical | Vascular hole closure delivery device |
US20110029013A1 (en) | 2008-02-15 | 2011-02-03 | Mcguckin James F | Vascular Hole Closure Device |
DK2265193T3 (en) | 2008-04-21 | 2012-01-23 | Nfocus Neuromedical Inc | Embolic devices with braided ball and delivery systems |
EP2280755A1 (en) | 2008-05-01 | 2011-02-09 | Aneuclose LLC | Aneurysm occlusion device |
US20210401440A1 (en) * | 2008-05-01 | 2021-12-30 | Aneuclose Llc | Janjua Aneurysm Net with a Stiff Proximal Portion and a Flexible Distal Portion |
US11944316B2 (en) * | 2008-05-01 | 2024-04-02 | Aneuclose Llc | Janjua aneurysm net and other intrasacular aneurysm occlusion devices |
US11464518B2 (en) * | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US20220287719A1 (en) * | 2008-05-01 | 2022-09-15 | Aneuclose Llc | Intrasacular Aneurysm Occlusion Device with Embolic Members Inserted between an Outer Mesh and an Inner Mesh |
US11484322B2 (en) | 2018-01-03 | 2022-11-01 | Aneuclose Llc | Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac |
US11357511B2 (en) * | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
US11471164B2 (en) * | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
US11471163B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies |
US20230035074A1 (en) * | 2010-10-21 | 2023-02-02 | Aneuclose Llc | Intrasacular Aneurysm Occlusion Device with Nested Structures |
CN106974691A (en) | 2008-05-02 | 2017-07-25 | 斯昆特医疗公司 | Thread device for treating vascular defects |
WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
AU2009274126A1 (en) * | 2008-07-22 | 2010-01-28 | Covidien Lp | Vascular remodeling device |
US20100069948A1 (en) * | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
JP5564058B2 (en) * | 2008-12-10 | 2014-07-30 | マイクロベンション インコーポレイテッド | Microcatheter |
US10702275B2 (en) * | 2009-02-18 | 2020-07-07 | St. Jude Medical Cardiology Division, Inc. | Medical device with stiffener wire for occluding vascular defects |
US20110152993A1 (en) * | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
CN102791205B (en) | 2009-11-09 | 2016-02-03 | 恩福克斯神经医学股份有限公司 | Embolization device |
US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
JP4499831B1 (en) * | 2010-01-22 | 2010-07-07 | 規方 田熊 | Aneurysm embolizer |
WO2011094634A1 (en) | 2010-01-28 | 2011-08-04 | Micro Therapeutics, Inc. | Vascular remodeling device |
CN102740799A (en) | 2010-01-28 | 2012-10-17 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
US8425548B2 (en) | 2010-07-01 | 2013-04-23 | Aneaclose LLC | Occluding member expansion and then stent expansion for aneurysm treatment |
US20120080478A1 (en) | 2010-09-30 | 2012-04-05 | Ethicon Endo-Surgery, Inc. | Surgical staple cartridges with detachable support structures and surgical stapling instruments with systems for preventing actuation motions when a cartridge is not present |
EP2484310A1 (en) * | 2011-02-08 | 2012-08-08 | Biotronik AG | Heart valve prosthesis with flexible fixations and deployment device therefor |
JP5868432B2 (en) | 2011-02-11 | 2016-02-24 | コヴィディエン リミテッド パートナーシップ | Two-stage deployed aneurysm embolization device |
JP6066931B2 (en) | 2011-02-25 | 2017-01-25 | マイクロベンション インコーポレイテッド | Reinforced balloon catheter |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US9138232B2 (en) | 2011-05-24 | 2015-09-22 | Aneuclose Llc | Aneurysm occlusion by rotational dispensation of mass |
US9017366B2 (en) * | 2011-08-19 | 2015-04-28 | Empirilon Technology, Llc | Methods and systems for performing intralumenal procedures |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
US9289307B2 (en) | 2011-10-18 | 2016-03-22 | Ortho-Space Ltd. | Prosthetic devices and methods for using same |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US20150005811A1 (en) * | 2012-01-06 | 2015-01-01 | Inceptus Medical, Llc | Expandable occlusion devices and methods of use |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
WO2013125330A1 (en) * | 2012-02-24 | 2013-08-29 | テルモ株式会社 | Medical device |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
WO2014078458A2 (en) * | 2012-11-13 | 2014-05-22 | Covidien Lp | Occlusive devices |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9662119B2 (en) * | 2013-03-13 | 2017-05-30 | Lawrence Livermore National Security, Llc | Shape-memory polymer foam device for treating aneurysms |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
WO2014144980A1 (en) | 2013-03-15 | 2014-09-18 | Covidien Lp | Occlusive device |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
US9539041B2 (en) | 2013-09-12 | 2017-01-10 | DePuy Synthes Products, Inc. | Minimally invasive biomaterial injection system |
JP6661539B2 (en) | 2013-12-20 | 2020-03-11 | テルモ株式会社 | Vessel closure |
US10045786B2 (en) * | 2013-12-20 | 2018-08-14 | Microvention, Inc. | Expansile member |
EP3102122A1 (en) * | 2014-02-06 | 2016-12-14 | Boston Scientific Scimed, Inc. | Occlusion device detachable by inflation of a balloon |
US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
EP3136986B1 (en) | 2014-04-30 | 2019-04-17 | Cerus Endovascular Limited | Occlusion device |
US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
US10857012B2 (en) | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
EP3247285B1 (en) | 2015-01-20 | 2021-08-11 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms |
US10959761B2 (en) | 2015-09-18 | 2021-03-30 | Ortho-Space Ltd. | Intramedullary fixated subacromial spacers |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
ES2912136T3 (en) | 2015-12-07 | 2022-05-24 | Cerus Endovascular Ltd | occlusion device |
CA3016679A1 (en) | 2016-03-11 | 2017-09-14 | Cerus Endovascular Limited | Occlusion device |
US10898203B2 (en) | 2016-05-18 | 2021-01-26 | Microvention, Inc. | Embolic containment |
US10555738B2 (en) | 2016-05-18 | 2020-02-11 | Microvention, Inc. | Embolic containment |
US10420563B2 (en) * | 2016-07-08 | 2019-09-24 | Neurogami Medical, Inc. | Delivery system insertable through body lumen |
CN113215721B (en) | 2016-10-14 | 2023-02-17 | 因赛普特斯医学有限责任公司 | Knitting machine and method of use |
US11045981B2 (en) | 2017-01-30 | 2021-06-29 | Ortho-Space Ltd. | Processing machine and methods for processing dip-molded articles |
US10376267B2 (en) | 2017-02-24 | 2019-08-13 | Inceptus Medical, Llc | Vascular occlusion devices and methods |
MX2020001999A (en) | 2017-08-21 | 2020-07-20 | Cerus Endovascular Ltd | Occlusion device. |
US11885051B2 (en) | 2017-10-14 | 2024-01-30 | Inceptus Medical, Llc | Braiding machine and methods of use |
US11399845B2 (en) | 2017-12-12 | 2022-08-02 | Penumbra, Inc. | Vascular cages and methods of making and using the same |
WO2020093012A1 (en) | 2018-11-01 | 2020-05-07 | Terumo Corporation | Occlusion systems |
US11504105B2 (en) | 2019-01-25 | 2022-11-22 | Rex Medical L.P. | Vascular hole closure device |
CN113573765A (en) | 2019-03-15 | 2021-10-29 | 后续医疗股份有限公司 | Silk device for treating vascular defects |
EP3908208A4 (en) | 2019-03-15 | 2022-10-19 | Sequent Medical, Inc. | Filamentary devices having a flexible joint for treatment of vascular defects |
CN113556985A (en) | 2019-03-15 | 2021-10-26 | 后续医疗股份有限公司 | Silk device for treating vascular defects |
EP4054438A1 (en) | 2019-11-04 | 2022-09-14 | Covidien LP | Devices, systems, and methods for treatment of intracranial aneurysms |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2849002A (en) * | 1956-03-12 | 1958-08-26 | Vincent J Oddo | Haemostatic catheter |
US4364392A (en) * | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4705517A (en) * | 1985-09-03 | 1987-11-10 | Becton, Dickinson And Company | Percutaneously deliverable intravascular occlusion prosthesis |
US4710192A (en) * | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5334210A (en) * | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5454833A (en) * | 1993-07-21 | 1995-10-03 | Laboratoire, Nycomed S.A. | System for temporarily obturating an orifice in a perforated organ, such as a vessel |
US5456693A (en) * | 1992-09-21 | 1995-10-10 | Vitaphore Corporation | Embolization plugs for blood vessels |
US5522822A (en) * | 1992-10-26 | 1996-06-04 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5522836A (en) * | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
US5534024A (en) * | 1994-11-04 | 1996-07-09 | Aeroquip Corporation | Intraluminal stenting graft |
US5749894A (en) * | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5899917A (en) * | 1997-03-12 | 1999-05-04 | Cardiosynopsis, Inc. | Method for forming a stent in situ |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US5976174A (en) * | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US6033426A (en) * | 1997-07-29 | 2000-03-07 | Olympus Optical Co., Ltd. | Access device for surgical treatment |
US6036720A (en) * | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6077291A (en) * | 1992-01-21 | 2000-06-20 | Regents Of The University Of Minnesota | Septal defect closure device |
US6086577A (en) * | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6096034A (en) * | 1996-07-26 | 2000-08-01 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US6139564A (en) * | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
US6168592B1 (en) * | 1996-07-26 | 2001-01-02 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US6168570B1 (en) * | 1997-12-05 | 2001-01-02 | Micrus Corporation | Micro-strand cable with enhanced radiopacity |
US6168615B1 (en) * | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US6193708B1 (en) * | 1997-08-05 | 2001-02-27 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (I) |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6293960B1 (en) * | 1998-05-22 | 2001-09-25 | Micrus Corporation | Catheter with shape memory polymer distal tip for deployment of therapeutic devices |
US6312421B1 (en) * | 1999-07-23 | 2001-11-06 | Neurovasx, Inc. | Aneurysm embolization material and device |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6350270B1 (en) * | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US20020082620A1 (en) * | 2000-12-27 | 2002-06-27 | Elaine Lee | Bioactive materials for aneurysm repair |
US6428558B1 (en) * | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US6454780B1 (en) * | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US20030028209A1 (en) * | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US7153323B1 (en) * | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989006984A1 (en) | 1988-01-27 | 1989-08-10 | Kievsky Nauchno-Issledovatelsky Institut Neirokhir | Occluding device |
IL106946A0 (en) | 1992-09-22 | 1993-12-28 | Target Therapeutics Inc | Detachable embolic coil assembly |
US5795331A (en) | 1994-01-24 | 1998-08-18 | Micro Therapeutics, Inc. | Balloon catheter for occluding aneurysms of branch vessels |
EP0769926B2 (en) | 1994-07-08 | 2006-11-22 | ev3 Inc. | Intravascular filtering device |
CA2162620A1 (en) | 1994-11-11 | 1996-05-12 | Gene Samson | Microcatheter-less coil delivery device |
US6312407B1 (en) | 1995-06-05 | 2001-11-06 | Medtronic Percusurge, Inc. | Occlusion of a vessel |
US5996397A (en) * | 1997-03-07 | 1999-12-07 | Breakthrough Technologies, Inc. | Reactive gas sampling/analyzing hygrometry system |
EP0882428A3 (en) | 1997-06-05 | 2000-06-14 | Medtronic Ave, Inc. | Intravascular occlusion device |
FR2765596B1 (en) | 1997-07-04 | 1999-08-27 | Commissariat Energie Atomique | PROCESS FOR SEPARATING TECHNETIUM FROM A NITRIC SOLUTION |
GB9715241D0 (en) | 1997-07-18 | 1997-09-24 | Jeffree Martin A | Device for treating aneurysms |
CA2298637A1 (en) | 1997-08-04 | 1999-02-11 | Jennifer J. Mccrory | Occlusion system for aneurysm repair |
WO1999039649A1 (en) | 1998-02-10 | 1999-08-12 | Dubrul William R | Occlusion, anchoring, tensioning and flow direction apparatus and methods for use |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
-
2002
- 2002-03-27 US US10/107,689 patent/US7695488B2/en not_active Expired - Fee Related
-
2003
- 2003-03-27 WO PCT/US2003/009324 patent/WO2003082128A1/en active Application Filing
- 2003-03-27 EP EP03714420A patent/EP1487354A1/en not_active Withdrawn
- 2003-03-27 CA CA002477380A patent/CA2477380A1/en not_active Abandoned
- 2003-03-27 AU AU2003218420A patent/AU2003218420A1/en not_active Abandoned
- 2003-03-27 JP JP2003579675A patent/JP2005527271A/en active Pending
-
2009
- 2009-09-30 JP JP2009229007A patent/JP2010022845A/en not_active Abandoned
-
2010
- 2010-03-11 US US12/721,834 patent/US20100168781A1/en not_active Abandoned
Patent Citations (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2849002A (en) * | 1956-03-12 | 1958-08-26 | Vincent J Oddo | Haemostatic catheter |
US4364392A (en) * | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4705517A (en) * | 1985-09-03 | 1987-11-10 | Becton, Dickinson And Company | Percutaneously deliverable intravascular occlusion prosthesis |
US4710192A (en) * | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US6077291A (en) * | 1992-01-21 | 2000-06-20 | Regents Of The University Of Minnesota | Septal defect closure device |
US5456693A (en) * | 1992-09-21 | 1995-10-10 | Vitaphore Corporation | Embolization plugs for blood vessels |
US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5522822A (en) * | 1992-10-26 | 1996-06-04 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
US5334210A (en) * | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5454833A (en) * | 1993-07-21 | 1995-10-03 | Laboratoire, Nycomed S.A. | System for temporarily obturating an orifice in a perforated organ, such as a vessel |
US5522836A (en) * | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
US5534024A (en) * | 1994-11-04 | 1996-07-09 | Aeroquip Corporation | Intraluminal stenting graft |
US5749894A (en) * | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
US6344041B1 (en) * | 1996-07-26 | 2002-02-05 | David Kupiecki | Aneurysm closure device assembly |
US6168592B1 (en) * | 1996-07-26 | 2001-01-02 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US6096034A (en) * | 1996-07-26 | 2000-08-01 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5782860A (en) * | 1997-02-11 | 1998-07-21 | Biointerventional Corporation | Closure device for percutaneous occlusion of puncture sites and tracts in the human body and method |
US5899917A (en) * | 1997-03-12 | 1999-05-04 | Cardiosynopsis, Inc. | Method for forming a stent in situ |
US6344048B1 (en) * | 1997-07-10 | 2002-02-05 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6033426A (en) * | 1997-07-29 | 2000-03-07 | Olympus Optical Co., Ltd. | Access device for surgical treatment |
US6383174B1 (en) * | 1997-08-05 | 2002-05-07 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (II) |
US6193708B1 (en) * | 1997-08-05 | 2001-02-27 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (I) |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US5916235A (en) * | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US6086577A (en) * | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6168570B1 (en) * | 1997-12-05 | 2001-01-02 | Micrus Corporation | Micro-strand cable with enhanced radiopacity |
US6036720A (en) * | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US5976174A (en) * | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US6168615B1 (en) * | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US6293960B1 (en) * | 1998-05-22 | 2001-09-25 | Micrus Corporation | Catheter with shape memory polymer distal tip for deployment of therapeutic devices |
US6139564A (en) * | 1998-06-16 | 2000-10-31 | Target Therapeutics Inc. | Minimally occlusive flow disruptor stent for bridging aneurysm necks |
US5935148A (en) * | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6063104A (en) * | 1998-06-24 | 2000-05-16 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
US6428558B1 (en) * | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6312421B1 (en) * | 1999-07-23 | 2001-11-06 | Neurovasx, Inc. | Aneurysm embolization material and device |
US6299619B1 (en) * | 1999-10-04 | 2001-10-09 | Microvention, Inc. | Methods for embolizing a target vascular site |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6350270B1 (en) * | 2000-01-24 | 2002-02-26 | Scimed Life Systems, Inc. | Aneurysm liner |
US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US7153323B1 (en) * | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
US20020082620A1 (en) * | 2000-12-27 | 2002-06-27 | Elaine Lee | Bioactive materials for aneurysm repair |
US6454780B1 (en) * | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US20030028209A1 (en) * | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
US20040098027A1 (en) * | 2001-07-31 | 2004-05-20 | Scimed Life Systems, Inc. | Expandable body cavity liner device |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US9277923B2 (en) | 2009-03-31 | 2016-03-08 | Barking Havering & Redbridge Hospitals Nhs Trust | Balloon assisted occlusion of aneurysms |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
WO2014117127A1 (en) * | 2013-01-28 | 2014-07-31 | Neurodynamics, LLC | Embolic coil delivery system and method of using same |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11890020B2 (en) | 2017-02-23 | 2024-02-06 | DePuy Synthes Products, Inc. | Intrasaccular aneurysm treatment device with varying coatings |
US11672543B2 (en) | 2017-02-23 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm method and system |
US11672540B2 (en) | 2018-01-24 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11058430B2 (en) | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11583288B2 (en) | 2018-08-08 | 2023-02-21 | DePuy Synthes Products, Inc. | Delivery of embolic braid |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11076861B2 (en) | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11633191B2 (en) | 2018-10-12 | 2023-04-25 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11272939B2 (en) | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11583282B2 (en) | 2019-05-21 | 2023-02-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
Also Published As
Publication number | Publication date |
---|---|
JP2010022845A (en) | 2010-02-04 |
US20030187473A1 (en) | 2003-10-02 |
EP1487354A1 (en) | 2004-12-22 |
AU2003218420A1 (en) | 2003-10-13 |
JP2005527271A (en) | 2005-09-15 |
CA2477380A1 (en) | 2003-10-09 |
US7695488B2 (en) | 2010-04-13 |
WO2003082128A1 (en) | 2003-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7695488B2 (en) | Expandable body cavity liner device | |
US8968352B2 (en) | Expandable body cavity liner device | |
US20210330331A1 (en) | Aneurysm occlusion device | |
US7153323B1 (en) | Aneurysm liner with multi-segment extender | |
US6350270B1 (en) | Aneurysm liner | |
US7083632B2 (en) | Aneurysm embolic device with an occlusive member | |
EP1006890B1 (en) | Occlusion system for aneurysm repair | |
US11382636B2 (en) | Mesh cap for ameliorating outpouchings | |
JP4447175B2 (en) | Embolization device for aneurysms inserted into blood vessels | |
EP1188413B1 (en) | Intravascular embolization device | |
US6254612B1 (en) | Hydraulic stent deployment system | |
US8328840B2 (en) | Methods and apparatus for rapid endovascular vessel occlusion and blood flow interruption | |
US20060206199A1 (en) | Aneurysm treatment devices | |
US20120310319A1 (en) | Stent | |
US20030083676A1 (en) | Aneurysm neck obstruction device | |
EP1312312A1 (en) | Aneurysm neck cover for sealing an aneurysm | |
US20060206198A1 (en) | Aneurysm treatment devices and methods | |
JP2001509412A (en) | Intravascular system for occluding an aneurysm | |
US20220249098A1 (en) | Filamentary devices for treatment of vascular defects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: STRYKER MEDTECH LIMITED, MALTA Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:037153/0034 Effective date: 20151013 Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:037153/0241 Effective date: 20151013 |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:038043/0011 Effective date: 20151013 Owner name: STRYKER MEDTECH LIMITED, MALTA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:038039/0001 Effective date: 20151013 |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC, MICHIGAN Free format text: CHANGE OF NAME;ASSIGNOR:STRYKER EUROPEAN HOLDINGS III, LLC;REEL/FRAME:052860/0716 Effective date: 20190226 Owner name: STRYKER EUROPEAN HOLDINGS III, LLC, DELAWARE Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER EUROPEAN HOLDINGS I, LLC;REEL/FRAME:052861/0001 Effective date: 20200519 |